Drug Discovery World

JANUARY 10, 2023

Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience. For many of our clients, we realise that cutting-edge research requires custom solutions. Antibody validation.

Antibody 52

Antibody Protein Reagent Scientist 52

pharmaphorum

AUGUST 16, 2020

“There are profound changes taking place in the area of life science research and development,” stated Swittons CEO and Founder Anupam Nandwana. In pharmaceutical lab settings, Swittons fills the gap between the scientist and the lab by automating functions such as: Trigger equipment maintenance. Reorder reagents.

Life Science 108

Life Science Reagent Scientist Clinical Trials 108

Drug Discovery World

SEPTEMBER 29, 2022

For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. Minimising reagent consumption and costs. Generating robust, reproducible data generating confidence in results.

Reagent 52

Reagent DNA Scientist Drugs 52

XTalks

JUNE 27, 2022

BD says it offers a “suite of open system reagents for the BD MAX System that enables labs to fully automate and streamline their Lab Developed Tests, and BD can partner with customers to develop complementary assays on the system.”.

Development 83

Development In-Vitro Reagent Vaccination 83

Drug Discovery World

SEPTEMBER 14, 2023

Many clinical and research laboratories today are having to do more with less: faced with ongoing staffing shortages, increased workloads, and budgetary constraints, many laboratory managers are feeling the stress, which is where the benefits of automation can be truly realised for labs in both academia and industry.

Reagent 111

Reagent Life Science Scientist DNA 111

XTalks

AUGUST 18, 2020

The test has been developed by researchers at the Yale School of Public Health and is being touted as a game changer for fast and easy COVID testing. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing. Non-Proprietary Technology.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Drug Discovery World

JUNE 28, 2023

Many clinical and research laboratories today are having to do more with less: faced with ongoing staffing shortages, increased workloads, and budgetary constraints, many laboratory managers are feeling the stress, which is where the benefits of automation can be truly realised for labs in both academia and industry.

Reagent 98

Reagent Life Science Scientist DNA 98

Drug Discovery World

FEBRUARY 16, 2023

We are always energised by our events: the opportunity to meet new people, see new products and technologies and hear the stories of how research is progressing and transforming. Their technologies range from data sciences to cell sciences, reagents to robotics, and microfluidics to virtual reality.

Life Science 52

Life Science Research Reagent Production 52

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. Dealing with confusing regulatory guidelines is one of the top obstacles researchers face as they develop CGT products 1. Recent Problems in Cell and Gene Therapy Development.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Genome 244

Genome Genomics Medicine Gene Therapy 244

Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

XTalks

OCTOBER 1, 2020

Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist 52

Scientist In-Vitro Research Life Science 52

Drug Discovery World

NOVEMBER 28, 2023

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. It is therefore much simpler and cheaper.

Protein 59

Protein Drugs Reagent Life Science 59

Pharmaceutical Technology

APRIL 28, 2023

The company has been ranked in the Business Expansion and Research and Development categories in the Pharmaceutical Technology Excellence Rankings. Key among them has been the extension of Syngene’s research collaboration with leading biotech company Amgen Inc. until 2026. until 2026.

Manufacturing 130

Manufacturing Antibody Clinical Supply Protein 130

The Pharma Data

JANUARY 22, 2021

Additional directives will foster research into new treatments for COVID-19, strengthen the collection and analysis of data to shape the government’s pandemic strategy; and direct the federal occupational safety agency to release and enforce guidelines to protect workers from getting infected, the Post reported.

Vaccination 52

Vaccination Vaccine Antibody Reagent 52

Drug Discovery World

FEBRUARY 15, 2023

The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. This is an exciting field of cancer research which involves harnessing the body’s own immune system to target cancerous cells.

Research 52

Research In-Vitro In-Vivo Development 52

Drug Discovery World

APRIL 13, 2023

Anything you can do to reduce costs is good – and savings on reagents are clearly a key driver for labs to miniaturise. When you try to scale down the volumes used in these methods, you soon run into a host of challenges around certain reagent types, different liquid viscosities, and tricky tasks such as bead clean-ups.

Genome 52

Genome Genomics Reagent Development 52

Drug Discovery World

DECEMBER 13, 2023

Moreover, custom antibodies are a key reagent in companion diagnostics for these novel therapeutics. Custom antibodies can be developed for pharmacokinetic assays and biodistribution assays, supporting therapeutic development by giving researchers data about the behaviour of their novel therapeutic in vivo.

Life Science 59

Life Science Antibody Manufacturing In-Vivo 59

XTalks

JANUARY 20, 2021

Laboratory research is among the industries where work cannot be completed from home. Access to laboratory reagents, equipment and research subjects is a necessity for researchers to complete their experimental work, as well as care for live cells, plants or animals. The iLab Software.

Research 97

Research Reagent Marketing Packaging 97

Drug Discovery World

NOVEMBER 30, 2023

coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents. This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It kb Influenza A hemagglutinin gene was used as a model system.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Drug Discovery World

FEBRUARY 27, 2023

The system features high-throughput fast dual detectors, enabling researchers to screen millions of samples with the increased accuracy, speed and sensitivity. This enables researchers to perform a wide range of assays for different applications within one instrument.

Drugs 52

Drugs Life Science Protein Scientist 52

Drug Discovery World

MARCH 13, 2023

Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed. Drug discovery researchers usually partner with a CDMO to provide support through the development, manufacturing, and clinical supply required to bring a drug to market.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

XTalks

APRIL 22, 2022

Receptor occupancy assays have been developed and applied in both nonclinical and clinical studies to provide insight into PK/PD relationships so far,” said Andre Olsson, PhD, Senior Scientist, Flow Cytometry at the global contract research organization (CRO) Medpace. When Can Receptor Occupancy be Used?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Antibody 98

Drug Discovery World

AUGUST 12, 2022

Some 5% of commercially available research compounds aresold as salt forms. By selecting the correct salt form for an assay or as a reagent, scientists can optimise their research projects, says Andrievs Auseklis Auzin, Developer, Molport, Latvia. The research chemical supply market. Conclusions.

Drugs 52

Drugs Bioassay Development Research 52

Drug Discovery World

JULY 18, 2023

Years of development and fast-paced research have continued to unlock its potential, expanding how CRISPR can be used to treat, detect, and prevent common diseases such as cancer and Covid-19. To address these issues, scientists are developing alternative CRISPR-based approaches that avoid DSBs, such as base editing and prime editing.

DNA 98

DNA Genome Genomics RNA 98

Drug Discovery World

OCTOBER 12, 2022

Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents such as monoclonal antibodies and other recombinant proteins.

Protein 52

Protein Gene Therapy Antibody Production 52

Drug Discovery World

JUNE 14, 2023

Blood and stem cell donors are often also willing to provide products for ethically approved research and development. To carry out the necessary research and development of manufacturing process, the company relies on blood products.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52

Drug Discovery World

OCTOBER 20, 2022

Dr Amber Miller, Flow Cytometry Scientist, Fortis Life Sciences, says flow cytometry techniques can help our understanding of cancer associated fibroblasts but there is still work to be done. This panel can be applied to other cancers or modified to better fit researchers’ or clinicians’ needs. Elaldi et al. 2016;165(4):780-791.

Antibody 52

Antibody In-Vivo Life Science Development 52

Drug Discovery World

OCTOBER 14, 2022

Arndt Aspe r ger , Senior Applications Scientist , Bruker Daltonics and M ei ke Hamester , Vice President Label-Free Technologies , Bruker Daltonics , examine how challenges in mass spectrometry for high-throughput screening can be overcome using a label-free approach. . Overcoming challenges in HTS using mass spectrometry . Asperger, M.

Drugs 52

Drugs In-Vitro Development Production 52

Drug Discovery World

AUGUST 23, 2023

Asks Matt Clifford , Director, Research and Innovation Strategy, IDBS. ” In many labs, a standard ELN represents the most frustrating part of a scientist’s day: toiling as a data entry clerk to provide data for other departments, without easy access to data themselves.

Laboratory Information Management System 52

Laboratory Information Management System Scientist Compliance Development 52

The Pharma Data

JANUARY 21, 2021

Other orders will foster research into new treatments for COVID-19, strengthen the collection and analysis of data to shape the government’s pandemic strategy; and direct the federal occupational safety agency to release and enforce guidelines to protect workers from getting infected, the Post reported. “It was a scary result.”

Vaccination 52

Vaccination Vaccine Antibody Reagent 52